Endocannabinoids in liver disease

Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis

(2010) Tzung-Yan Lee et al.   APOPTOSIS

CB1 Signaling in Forebrain and Sympathetic Neurons Is a Key Determinant of Endocannabinoid Actions on Energy Balance

(2010) Carmelo Quarta et al.   Cell Metabolism

CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice

(2010) T. Jourdan et al.   DIABETES

Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration

(2010) Fatima Teixeira-Clerc et al.   HEPATOLOGY

Transcriptional Regulation of Cannabinoid Receptor-1 Expression in the Liver by Retinoic Acid Acting via Retinoic Acid Receptor-γ

(2010) Bani Mukhopadhyay et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

(2010) Joseph Tam et al.   JOURNAL OF CLINICAL INVESTIGATION

Anandamide induces cell death through lipid rafts in hepatic stellate cells

(2010) Qiao Yang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet

(2009) Mélissa Flamment et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Adiponectin is required to mediate rimonabant-induced improvement of insulin sensitivity but not body weight loss in diet-induced obese mice

(2009) Stéphanie Migrenne et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Role of the Endocannabinoid System in Abdominal Obesity and the Implications for Cardiovascular Risk

(2009) Robert S. Rosenson   CARDIOLOGY

Cannabinoid Type 1 Receptor Antagonism Delays Ascites Formation in Rats With Cirrhosis

(2009) Marco Domenicali et al.   GASTROENTEROLOGY

Antagonism of the cannabinoid CB-1 receptor protects rat liver against ischaemia-reperfusion injury complicated by endotoxaemia

(2009) P. Caraceni et al.   GUT

Peripherally acting CB1-receptor antagonist: the relative importance of central and peripheral CB1 receptors in adiposity control

(2009) M-H Son et al.   INTERNATIONAL JOURNAL OF OBESITY

Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis

(2009) Annarosa Floreani et al.   JOURNAL OF GASTROENTEROLOGY

Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation

(2009) Iddo Magen et al.   JOURNAL OF HEPATOLOGY

Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis

(2009) Paolo Caraceni et al.   LIVER INTERNATIONAL

Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis

(2009) Vanessa Deveaux et al.   PLoS One

Cannabinoids and Capsaicin Improve Liver Function Following Thioacetamide-Induced Acute Injury in Mice

(2008) Yosefa Avraham et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Prevention of Hepatic Fibrosis in a Murine Model of Metabolic Syndrome with Nonalcoholic Steatohepatitis

(2008) Laurie D. DeLeve et al.   AMERICAN JOURNAL OF PATHOLOGY

Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver

(2008) Won-il Jeong et al.   Cell Metabolism

Selective CB1 cannabinoid receptor antagonist, SR141716A, attenuates liver injury induced by Concanavalin A

(2008) Midori Kojima et al.   HEPATOLOGY RESEARCH

Effects of rimonabant, a cannabinoid CB1 receptor ligand, on energy expenditure in lean rats

(2008) I Kunz et al.   INTERNATIONAL JOURNAL OF OBESITY

Rimonabant Ameliorates Insulin Resistance via both Adiponectin-dependent and Adiponectin-independent Pathways

(2008) Taku Watanabe et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Anandamide Biosynthesis Catalyzed by the Phosphodiesterase GDE1 and Detection of Glycerophospho-N-acyl Ethanolamine Precursors in Mouse Brain

(2008) Gabriel M. Simon et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

(2008) Douglas Osei-Hyiaman et al.   JOURNAL OF CLINICAL INVESTIGATION

Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids: Involvement of Regulatory T Cells

(2008) V. L. Hegde et al.   MOLECULAR PHARMACOLOGY

Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins

(2008) M. A. Ruby et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Anandamide inhibits cholangiocyte hyperplastic proliferation via activation of thioredoxin 1/redox factor 1 and AP-1 activation

(2007) Sharon DeMorrow et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

CB2 receptors as new therapeutic targets for liver diseases

(2007) S Lotersztajn et al.   BRITISH JOURNAL OF PHARMACOLOGY

Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C

(2007) Christophe Hézode et al.   GASTROENTEROLOGY